Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin and pioglitazone in the treatment of type 2 diabetes mellitus
IRCT2015061619554N4Phase 3Completed
- Sponsor
- Vice chancellor for research; Zanjan University of Medical Sciences
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sitagliptin and pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by Vice chancellor for research; Zanjan University of Medical Sciences. Started Apr 2016; status: completed.
02
Drugs
sitagliptinpioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT2015061619554N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015061619554N4.